-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Orphan Drug Designation to TuHURA Biosciences' IFx-2.0 for Cutaneous Melanoma

Reuters·02/02/2026 12:45:22

Please log in to view news